Clinical trial
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent…
NCT00387660 · University of California, Davis, Other · Completed
Key facts
| NCT number | NCT00387660 |
|---|---|
| Title | Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer |
| Official title | Phase II Study of Irinotecan and Carboplatin in Metastatic or Relapsed Small-Cell Lung Cancer |
| Lead sponsor | University of California, Davis, Other |
| Collaborators | National Cancer Institute (NCI) NIH Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, irinotecan |
| Enrollment | 80 |
| Start date | Oct 1, 2001 |
| Primary completion | Aug 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Oct 13, 2006 |
| Last update posted | Jan 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: